CSIMarket
 


Concert Pharmaceuticals Inc   (CNCE)
Other Ticker:  
 


Concert Pharmaceuticals Inc 's Free Cash Flow Margin by quarter

Trends, Rankings, Statistics



CNCE Free Cash Flow Margin (Sep 30 2017)
III. Quarter
(Jun 30 2017)
II. Quarter
(Dec 31 2016)
IV. Quarter
(Sep 30 2016)
III. Quarter
(Jun 30 2016)
II. Quarter
Y / Y Revenue Change 202497.18 % -73.21 % -99.8 % -98.48 % -99.87 %
Seq. Revenue Change 958860 % -28.57 % -19.23 % -63.38 % 26.79 %
Revenue In Millions $143.84 $0.02 $0.02 $0.03 $0.07
Free Cash Flow Margin 93.14 % - -54747.62 % -39753.85 % -13018.31 %
Free Cash Flow Margin Total Ranking # # # # #
Free Cash Flow In Millions $133.97 $21.81 $-11.50 $-10.34 $-9.24
Y / Y Free Cash Flow Change - - - - -
Seq. Free Cash Flow Change 514.32 % - - - -


Commenting Third Quarter 2017 Free Cash Flow Margin
Company's Free Cash Flow Margin decreased in III. Quarter to 93.14 %, below company's average Free Cash Flow Margin.

Observing third quarter 2017 results within Major Pharmaceutical Preparations industry Concert Pharmaceuticals Inc has achieved highest Free Cash Flow Margin. While overall Free Cash Flow Margin ranking remained unchanged compare to previous quarter at no. .

CNCE's Free Cash Flow Margin third quarter 2017 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall # 0

Free Cash Flow Margin Statistics
High Average Low
145386.67 % 29119.6 % 8.64 %
(Jun 30 2017)   (Dec 31 2015)




Other Free Cash Flow Margin Profitability Ratios
CNCE's Cumulative Free Cash Flow Margin
Major Pharmaceutical Preparations Industry Free Cash Flow Margin Trends and Statistics
Healthcare Sector Free Cash Flow Margin Statistics
Free Cash Flow Margin Profitability Trends for overall market
CNCE's Free Cash Flow Margin Profitability versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Free Cash Flow Margin
Lowest Ranking Free Cash Flow Margin
Free Cash Flow Margin Profit Margin for CNCE's Competitors
Free Cash Flow Margin Profit Margin for Concert Pharmaceuticals Inc 's Suppliers
Free Cash Flow Margin Profit Margin for CNCE's Customers

You may also want to know
CNCE's Annual Growth Rates CNCE's Profitability Ratios CNCE's Asset Turnover Ratio CNCE's Dividend Growth
CNCE's Roe CNCE's Valuation Ratios CNCE's Financial Strength Ratios CNCE's Free Cash Flow Growth
CNCE's Roa CNCE's Inventory Turnover Ratio CNCE's Growth Rates CNCE's Dividend Comparisons


Companies with similar Free Cash Flow Margin in the quarter ending Sep 30 2017, within Major Pharmaceutical Preparations Industry Free Cash Flow MarginSep 30 2017 MRQ Free Cash FlowSep 30 2017 MRQ Revenue
Concert Pharmaceuticals Inc   93.14 %$ 133.971 $ 143.844 
Biospecifics Technologies Corp  92.89 %$ 6.053 $ 6.516 
Innoviva Inc   89.41 %$ 43.490 $ 48.643 
Xoma Corporation  84.75 %$ 30.666 $ 36.183 
Ligand Pharmaceuticals Incorporated  82.85 %$ 27.650 $ 33.375 
Avalo Therapeutics Inc   76.29 %$ 19.100 $ 25.038 
Enanta Pharmaceuticals Inc  75.48 %$ 57.306 $ 75.927 
Eagle Pharmaceuticals inc   72.09 %$ 45.434 $ 63.021 
Intelgenx Technologies Corp   66.83 %$ 0.838 $ 1.254 
Nektar Therapeutics  60.86 %$ 93.076 $ 152.928 
United Therapeutics Corporation  58.02 %$ 258.500 $ 445.500 
Supernus Pharmaceuticals inc   48.51 %$ 39.005 $ 80.398 
Abbvie inc   46.76 %$ 3,271.000 $ 6,995.000 
Jazz Pharmaceuticals Plc  45.86 %$ 188.897 $ 411.855 
Teva Pharmaceutical Industries Limited  41.50 %$ 2,328.000 $ 5,610.000 
China Yct International Group, Inc.  37.40 %$ 5.186 $ 13.867 
Mylan N v   37.37 %$ 1,116.400 $ 2,987.100 
Allergan plc  36.50 %$ 1,472.400 $ 4,034.300 
Ani Pharmaceuticals Inc  35.47 %$ 17.084 $ 48.164 
Eli Lilly And Company  33.25 %$ 1,881.100 $ 5,658.000 
Celgene Corp  33.10 %$ 1,088.000 $ 3,287.000 
Bristol myers Squibb Company  32.60 %$ 1,713.000 $ 5,254.000 
Zoetis Inc   32.59 %$ 439.000 $ 1,347.000 
Johnson and Johnson  31.89 %$ 6,266.000 $ 19,650.000 
Alexion Pharmaceuticals Inc   31.43 %$ 270.000 $ 859.000 
Cambrex Corp  31.09 %$ 35.008 $ 112.619 
Vertex Pharmaceuticals Inc  29.42 %$ 170.086 $ 578.165 
Abbott Laboratories  29.36 %$ 2,005.000 $ 6,829.000 
Mallinckrodt Plc  28.47 %$ 226.000 $ 793.900 
Regeneron Pharmaceuticals Inc   27.64 %$ 414.832 $ 1,500.673 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com